Impax Asset Management Group plc lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 28.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 442,763 shares of the semiconductor company's stock after selling 179,146 shares during the quarter. Synopsys comprises approximately 1.3% of Impax Asset Management Group plc's portfolio, making the stock its 21st biggest holding. Impax Asset Management Group plc owned 0.23% of Synopsys worth $207,975,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management boosted its position in Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. boosted its position in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC bought a new position in Synopsys during the third quarter worth about $27,000. SOA Wealth Advisors LLC. bought a new position in Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC bought a new position in Synopsys during the third quarter worth about $29,000. Institutional investors own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on SNPS. HSBC downgraded shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target on the stock. in a report on Friday, February 20th. Piper Sandler lowered their price target on shares of Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Weiss Ratings reissued a "hold (c)" rating on shares of Synopsys in a report on Thursday, January 22nd. Rosenblatt Securities lowered their price target on shares of Synopsys from $560.00 to $530.00 and set a "buy" rating on the stock in a report on Thursday, February 26th. Finally, Needham & Company LLC reaffirmed a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $531.00.
View Our Latest Report on Synopsys
Synopsys Trading Up 9.6%
Shares of SNPS opened at $500.82 on Friday. The firm's 50 day simple moving average is $426.02 and its 200 day simple moving average is $445.33. The company has a market capitalization of $95.94 billion, a P/E ratio of 77.77, a P/E/G ratio of 3.73 and a beta of 1.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping the consensus estimate of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The business's revenue was up 65.6% compared to the same quarter last year. During the same period last year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts forecast that Synopsys, Inc. will post 10.3 earnings per share for the current fiscal year.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.